Personensuche
Personensuche
Es wurde 1 Person gefunden.
Klinik für Nuklearmedizin am Universitätsklinikum Essen
Anschrift
Hufelandstr. 55
45122 Essen
45122 Essen
E-Mail
Funktionen
-
Universitätsprofessor/in, Klinik für Nuklearmedizin
Aktuelle Veranstaltungen
-
WiSe 2025
- POL - Nuklearmedizin
- Anleitung zu selbständigen wissenschaftlichen Arbeiten in der Nuklearmedizin
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Klinische Nuklearmedizin: Grundlagen und Indikationen
- Moderne metabolische / funktionelle Schnittbildgebung - Standards in der klinischen Versorgung
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
- Anleitung zu selbständigen wissenschaftlichen Arbeiten in der Nuklearmedizin
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Moderne metabolische / funktionelle Schnittbildgebung - Standards in der klinischen Versorgung
- Klinische Nuklearmedizin: Grundlagen und Indikationen
- POL - Nuklearmedizin
-
WiSe 2024
- Anleitung zu selbständigen wissenschaftlichen Arbeiten in der Nuklearmedizin
- POL - Nuklearmedizin
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Klinische Nuklearmedizin: Grundlagen und Indikationen
- Moderne metabolische / funktionelle Schnittbildgebung - Standards in der klinischen Versorgung
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Diagnostic accuracy of Afirma gene expression classifier, Afirma gene sequencing classifier, ThyroSeq v2 and ThyroSeq v3 for indeterminate (Bethesda III and IV) thyroid nodules : A meta-analysisIn: Endocrine Connections, Jg. 13, 2024, Nr. 7, e240170DOI (Open Access)
-
Diagnostic, Theranostic and Prognostic Value of Thyroglobulin in Thyroid CancerIn: Journal of Clinical Medicine (JCM), Jg. 13, 2024, Nr. 9, 2463DOI (Open Access)
-
Interobserver Agreement in Ultrasound Risk Stratification Systems for Thyroid Nodules on Static Images Versus Cine-Loop Video SequencesIn: Diagnostics, Jg. 14, 2024, Nr. 19, 2138DOI (Open Access)
-
Risk and Incidence of Endocrine Immune-Related Adverse Effects under Checkpoint Inhibitor Mono- or Combination Therapy in Solid Tumors : A Meta-Analysis of Randomized Controlled TrialsIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 109, 2024, Nr. 4, S. 1132 – 1144
-
Thyroglobulin measurement is the most powerful outcome predictor in differentiated thyroid cancer : a decision tree analysis in a European multicenter seriesIn: Clinical Chemistry and Laboratory Medicine, Jg. 62, 2024, Nr. 11, S. 2307 – 2315
-
Thyroid Imaging Reporting and Data Systems : Applicability of the “Taller than Wide” Criterium in Primary/Secondary Care Units and the Role of Thyroid ScintigraphyIn: Journal of Clinical Medicine (JCM), Jg. 13, 2024, Nr. 2, 514DOI (Open Access)
-
Correct and Incorrect Recommendations for or against Fine Needle Biopsies of Hypofunctioning Thyroid Nodules : Performance of Different Ultrasound-based Risk Stratification SystemsIn: Nuklearmedizin = Nuclear Medicine, Jg. 63, 2023, Nr. 1, S. 21 – 33
-
Postoperative thyroglobulin as a yard-stick for radioiodine therapy : decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancerIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 50, 2023, Nr. 9, S. 2767 – 2774DOI (Open Access)
-
Predictive value of highly sensitive basal versus stimulated thyroglobulin measurement in long-term follow-up of thyroid cancerIn: Endocrine Connections, Jg. 12, 2023, Nr. 2, e220312DOI, Online Volltext (Open Access)
-
Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensusIn: European Journal of Endocrinology (EJE), Jg. 189, 2023, Nr. 2, S. R11 – R27DOI (Open Access)
-
Thyroid Hormone Withdrawal versus Recombinant Human TSH as Preparation for I-131 Therapy in Patients with Metastatic Thyroid Cancer : A Systematic Review and Meta-AnalysisIn: Cancers, Jg. 15, 2023, Nr. 9, 2510DOI (Open Access)
-
Update on Calcitonin Screening for Medullary Thyroid Carcinoma and the Results of a Retrospective Analysis of 12,984 Patients with Thyroid NodulesIn: Cancers, Jg. 15, 2023, Nr. 8, 2333DOI (Open Access)
-
Diagnostic Performance of⁹⁹m Tc-Methoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules : A European Multicenter StudyIn: Diagnostics, Jg. 12, 2022, Nr. 6, 1358DOI (Open Access)
-
Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in GermanyIn: Nuklearmedizin = Nuclear Medicine, Jg. 61, 2022, Nr. 5, S. 376 – 384
-
Introducing a Pole Concept for Nodule Growth in the Thyroid Gland : Taller-than-Wide Shape, Frequency, Location and Risk of Malignancy of Thyroid Nodules in an Area with Iodine DeficiencyIn: Journal of Clinical Medicine (JCM), Jg. 11, 2022, Nr. 9, 2549DOI (Open Access)
-
The role of thyroglobulin doubling time in differentiated thyroid cancer : A meta-analysisIn: Endocrine Connections, Jg. 11, 2022, Nr. 4, e210648DOI (Open Access)
-
Analysis of risk factors and prognosis in differentiated thyroid cancer with focus on minimal extrathyroidal extensionIn: BMC Endocrine Disorders, Jg. 21, 2021, Nr. 1, 161DOI, Online Volltext (Open Access)
-
Diagnostic accuracy of routine calcitonin measurement for the detection of medullary thyroid carcinoma in the management of patients with nodular thyroid disease : A meta-analysisIn: Endocrine Connections, Jg. 10, 2021, Nr. 3, S. 358 – 370DOI (Open Access)
-
Diagnostic performance of kwak, eu, acr, and korean tirads as well as ata guidelines for the ultrasound risk stratification of non-autonomously functioning thyroid nodules in a region with long history of iodine deficiency : A German multicenter trialIn: Cancers, Jg. 13, 2021, Nr. 17, 4467DOI (Open Access)
-
Evaluation of a new automated assay for high-sensitivity thyroglobulin measurement and comparison with two established high-sensitivity thyroglobulin assaysIn: Practical Laboratory Medicine, Jg. 26, 2021, e00250DOI, Online Volltext (Open Access)
-
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTCIn: Cancers, Jg. 13, 2021, Nr. 7, S. 1728DOI, Online Volltext (Open Access)
-
Update on diagnosis and treatment of hyperthyroidism : ultrasonography and functional imagingIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 65, 2021, Nr. 2, S. 102 – 112
-
A matter of controversy : Is radioiodine therapy favorable in differentiated thyroid carcinoma?In: Chinese Journal of Nuclear Medicine and Molecular Imaging, Jg. 40, 2020, Nr. 1, S. 56 – 61DOI (Open Access)
-
Correction for hyperfunctioning radiation-induced stunning (CHRIS) in benign thyroid diseasesIn: Endocrine, Jg. 69, 2020, Nr. 2, S. 466 – 473
-
Diagnostic Performance of Different Thyroid Imaging Reporting and Data Systems (Kwak-TIRADS, EU-TIRADS and ACR TI-RADS) for Risk Stratification of Small Thyroid Nodules (≤10 mm)In: Journal of Clinical Medicine (JCM), Jg. 9, 2020, Nr. 1, 236DOI (Open Access)
-
Interobserver agreement and efficacy of consensus reading in Kwak-, EU-, and ACR-thyroid imaging recording and data systems and ATA guidelines for the ultrasound risk stratification of thyroid nodulesIn: Endocrine, Jg. 67, 2020, Nr. 1, S. 143 – 154
-
Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients : a meta-analysisIn: BMC Cancer, Jg. 20, 2020, Nr. 1, 550DOI (Open Access)
-
Changing trends of incidence and prognosis of thyroid carcinomaIn: Nuklearmedizin = Nuclear Medicine, Jg. 58, 2019, Nr. 2, S. 86 – 92
-
Risk stratification of thyroid nodules using the Thyroid Imaging Reporting and Data System (TIRADS) : The omission of thyroid scintigraphy increases the rate of falsely suspected lesionsIn: Journal of Nuclear Medicine (JNM), Jg. 60, 2019, Nr. 3, S. 342 – 347DOI (Open Access)
-
Thyroid Related Quality of Life in Elderly with Subclinical Hypothyroidism and Improvement on Levothyroxine is Distinct from that in Young Patients (TSAGE)In: Hormone and Metabolic Research, Jg. 51, 2019, Nr. 9, S. 568 – 574
-
A matter of controversy : Is radioiodine therapy favorable in differentiated thyroid carcinoma?In: Journal of Nuclear Medicine (JNM), Jg. 59, 2018, Nr. 8, S. 1195 – 1201DOI (Open Access)
-
18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography May Exclude Malignancy in Sonographically Suspicious and Scintigraphically Hypofunctional Thyroid Nodules and Reduce Unnecessary Thyroid SurgeriesIn: Thyroid, Jg. 27, 2017, Nr. 10, S. 1300 – 1306
-
68Ga-DOTATOC PET/CT in Patients with Iodine- and 18F-FDG-Negative Differentiated Thyroid Carcinoma and Elevated Serum ThyroglobulinIn: Journal of Nuclear Medicine (JNM), Jg. 57, 2016, Nr. 10, S. 1512 – 1517DOI (Open Access)
-
Calcitonin-Screening und StimulationstestsIn: Der Nuklearmediziner, Jg. 39, 2016, Nr. 02, S. 111 – 119
-
Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancerIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 43, 2016, Nr. 11, S. 1988 – 1994
-
Serum Thyroglobulin Doubling Time in Progressive Thyroid CancerIn: Thyroid, Jg. 26, 2016, Nr. 12, S. 1712 – 1718
-
Expression of the cAMP binding protein EPAC1 in thyroid tumors and growth regulation of thyroid cells and thyroid carcinoma cells by EPAC proteinsIn: Hormone and Metabolic Research, Jg. 47, 2015, Nr. 3, S. 200 – 208
-
Lowest effective 131I activity for thyroid remnant ablation of differentiated thyroid cancer patients : Dosimetry-based model for estimationIn: Nuklearmedizin = Nuclear Medicine, Jg. 54, 2015, Nr. 3, S. 137 – 143
-
Not all DTC patients with N positive disease deserve the attribution "high risk". Contribution of the MSDS trialIn: Journal of Surgical Oncology, Jg. 112, 2015, Nr. 1, S. 9 – 14
-
Diagnosis of hyperfunctional thyroidn odules : Impact of US-elastographyIn: Nuklearmedizin = Nuclear Medicine, Jg. 53, 2014, Nr. 5, S. 173 – 177
-
One novel and one rediscovered mutation in patients with resistance to thyroid hormoneIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 121, 2013, OP6_40
-
18F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapyIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 39, 2012, Nr. 9, S. 1373 – 1380
-
Assay-Abhängigkeit der Calcitonin- Zielbereiche für „biochemisch geheilte“ Patienten mit medullärem SchilddrüsenkarzinomIn: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 4, S. 125 – 132
-
Short-term hypothyroidism in thyroid cancer patients and cognitive-motor performance relevant for drivingIn: Psychoneuroendocrinology, Jg. 37, 2012, Nr. 10, S. 1726 – 1735
-
Success rate of repeated fine needle aspiration biopsy of clinically suspicious thyroid nodulesIn: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 4, S. 116 – 118
-
Ultrasound-guided fine-needle aspiration biopsy of clinically suspicious thyroid nodules with an automatic aspirator : A novel techniqueIn: Thyroid, Jg. 22, 2012, Nr. 7, S. 695 – 698
-
Basal and Stimulated Calcitonin and Procalcitonin by Various Assays in Patients with and without Medullary Thyroid CancerIn: Clinical Chemistry, Jg. 57, 2011, Nr. 3, S. 467 – 474
-
Optimierung der Schilddrüsen- Feinnadelpunktion : Automatischer Mikroaspirator versus manuelle TechnikIn: Nuklearmedizin = Nuclear Medicine, Jg. 50, 2011, Nr. 5, S. 189 – 194
-
Szintigraphisch mehranreichernde Schilddrüsenknoten gehen überwiegend mit normwertigem TSH einherIn: Nuklearmedizin = Nuclear Medicine, Jg. 50, 2011, Nr. 5, S. 179 – 188
-
Calcitonin screening and pentagastrin testing : Predictive value for the diagnosis of medullary carcinoma in nodular thyroid diseaseIn: European Journal of Endocrinology (EJE), Jg. 162, 2010, Nr. 6, S. 1141 – 1145DOI (Open Access)
-
Tumormarker für SchilddrüsenkarzinomeIn: TumorDiagnostik & Therapie, Jg. 31, 2010, Nr. 1, S. 29 – 38
-
Chemotherapy with doxorubicin in progressive medullary and thyroid carcinoma of the follicular epitheliumIn: Hormone and Metabolic Research, Jg. 40, 2008, Nr. 3, S. 210 – 213
-
124I-PET dosimetry in advanced differentiated thyroid cancer : therapeutic impactIn: Nuklearmedizin = Nuclear Medicine, Jg. 46, 2007, Nr. 4, S. 121 – 128
-
Economic Image Compression of Output Documentation of the Most Frequent Examinations in Nuclear MedicineIn: Academic Radiology, Jg. 14, 2007, Nr. 8, S. 967 – 973
-
Protektive Faktoren für Angst und Depression bei SchilddrüsenkarzinompatientenIn: Zeitschrift für Psychosomatische Medizin und Psychotherapie, Jg. 53, 2007, Nr. 1, S. 62 – 74
-
The C allele of the GNB3 C825T polymorphism of the G protein β3-subunit is associated with an increased risk for the development of oncocytic thyroid tumoursIn: The Journal of Pathology, Jg. 211, 2007, Nr. 1, S. 60 – 66
-
Health-related quality of life, depression and anxiety in thyroid cancer patientsIn: Quality of Life Research, Jg. 15, 2006, Nr. 4, S. 695 – 703
-
Optimizing preoperative imaging in primary hyperparathyroidismIn: Langenbeck's Archives of Surgery, Jg. 391, 2006, Nr. 6, S. 551 – 556
-
Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomyIn: European Journal of Endocrinology (EJE), Jg. 153, 2005, Nr. 1, S. 49 – 55
-
Die „Erleuchtung“ der Drüsen : nuklearmedizinische Diagnostik und Therapie endokriner TumorenIn: Essener Unikate: Berichte aus Forschung und Lehre, 2005, Nr. 25 : Medizin – Unsere Hormone, S. 86 – 97Online Volltext, Online Volltext (Open Access)
-
Different genotype distribution of the GNB3 C825T polymorphism of the G protein β3 subunit in adenomas and differentiated thyroid carcinomas of follicular cell originIn: The Journal of Pathology, Jg. 207, 2005, Nr. 4, S. 430 – 435
-
Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatmentIn: European Journal of Endocrinology, Jg. 153, 2005, Nr. 6, S. 755 – 763DOI (Open Access)
-
Prognostic value of c-erbB-2 expression in papillary thyroid carcinomaIn: Nuklearmedizin = Nuclear Medicine, Jg. 44, 2005, Nr. 5, S. 179 – 184
-
Impact of disease activity on thyroid diseases in patients with acromegaly : Basal evaluation and follow-upIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 112, 2004, Nr. 5, S. 225 – 230
-
Diagnostic value of high-resolution B-mode and power-mode sonography in the follow-up of thyroid cancerIn: European Journal of Ultrasound, Jg. 16, 2003, Nr. 3, S. 191 – 206
-
Diagnostic value of high-resolution B-mode and power-mode sonography in the follow-up of thyroid cancerIn: European Journal of Ultrasound, Jg. 16, 2003, Nr. 3, S. 191 – 206
-
Kontinuierliche Sensitivitätssteigerung in der Schilddrüsenkarzinom-Nachsorge im Verlauf dreier Thyreoglobulin-IMA-GenerationenIn: Nuklearmedizin = Nuclear Medicine, Jg. 42, 2003, Nr. 4, S. 157 – 166
-
Rasch progrdientes Rezidiv der kolumnären Variante eines papillären Schilddrüsenkarzinoms unter endogener TSH-StimulationIn: Nuklearmedizin = Nuclear Medicine, Jg. 42, 2003, Nr. 3, S. N15 – 18
-
Kombinierte PET/CT mit dem Positronenstrahler 124-I bei metastasiertem follikuären SchilddrüsenkarzinomIn: Nuklearmedizin = Nuclear Medicine, Jg. 41, 2002, Nr. 5, S. N68 – 71
-
Mimikri einer multiplen endokrinen Neoplasie mit Schilddrüsenbeteiligung durch das Spätrezidiv eines NierenzellkarzinomsIn: Nuklearmedizin = Nuclear Medicine, Jg. 41, 2002, Nr. 3, S. N24 – 26
-
Surveillance of TSH-Suppressive Levothyroxine Treatment in Thyroid Cancer Patients : TRH Testing Versus Basal TSH Determination by a Third Generation AssayIn: Experimental and Clinical Endocrinology & Diabetes, Jg. 110, 2002, Nr. 7, S. 355 – 360
-
Die endoskopische Exstirpation extraadrenaler Phäochromocytome (Paragangliome)In: Der Chirurg, Jg. 71, 2000, Nr. 12, S. 1504 – 1508
-
Improved Diagnostic Methods in the Follow-Up of Medullary Thyroid Carcinoma by Highly Specific Calcitonin MeasurementsIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 85, 2000, Nr. 5, S. 1890 – 1894DOI (Open Access)
-
Diagnosis of Cushing’s syndrome : Re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient groupIn: Journal of Endocrinological Investigation, Jg. 22, 1999, Nr. 4, S. 241 – 249DOI (Open Access)
-
Untersuchungen zum Somatostatinrezeptor-Status bei nicht-medullären SchilddrüsenkarzinomenIn: Nuklearmedizin = Nuclear Medicine, Jg. 38, 1999, Nr. 1, S. 15 – 23
-
Prädiktion der pharmakologischen Wirkung von Octreotid bei Akromegalie mittels 111In-Pentetreotid-Szintigraphie und Berechnung eines hypophysären Uptake-IndexIn: Nuklearmedizin = Nuclear Medicine, Jg. 36, 1997, Nr. 4, S. 117 – 124
-
Imaging of metastases from thyroid carcinomas using 111In-pentetreotide scintigraphyIn: Nuklearmedizin = Nuclear Medicine, Jg. 34, 1995, Nr. 4, S. 165 – 169
-
Diagnostic Performance of99mTc-methoxy-isobutyl- isonitrile (MIBI) Imaging in Hypofunctioning Thyroid Nodules : A European Multicenter Study
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S199DOI (Open Access) -
BRAF Mutation Analysis for Initial Risk Stratification in High Risk Papillary Thyroid CarcinomaIn: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. 551
-
Thyroid CancerIn: Molecular anatomic imaging: PET-CT, PET-MR, and SPECT-CT / von Schulthess, Gustav K. (Hrsg.): Wolters Kluwer Health Adis (ESP), 2016, S. 375 – 382
-
Calcitoninscreening bei Struma nodosa in der Versorgungsmedizin: Auswertung von >10.000 Fällen
53. DGN-Jahrestagung 2015; 24.04.2015; Hannover,Hannover, 2015 -
Calcitoninscreening bei Struma nodosa in der Versorgungsmedizin: Auswertung von >12.000 Fällen
34. Arbeitstagung der Chirurgischen Arbeitsgemeinschaft Endokrinologie (CAEK), 45. Jahrestagung der Sektion Schilddrüse der Deutschen Gesellschaft für Endokrinologie (DGE); 20.11.2015; Mainz,Mainz, 2015